The AJMC® COPD compendium is a comprehensive resource for clinical news and expert insights for chronic obstructive pulmonary disease.
May 16th 2024
Italian patients with chronic obstructive pulmonary disease (COPD) face a significantly increased risk of severe cardiovascular events.
Evolving Treatment Strategies in the Management of Pulmonary Arterial Hypertension: Key Insights for the Pharmacist, featuring a Patient Perspective
1.5 Credits / Pulmonology/Respiratory
View More
Advances in EGFR Exon 20 Insertion-Positive Non–Small Cell Lung Cancer: A Focus on Specialty Pharmacy Interventions
1.5 Credits / Oncology, Pulmonology/Respiratory
View More
Advances and Best Practices for Managed Care Pharmacists and the Treatment of Patients with Alpha-1 Antitrypsin Deficiency
1.0 Credit / Pulmonology/Respiratory
View More
Costs for Patients With Alpha-1 Antitrypsin Form of COPD Are Higher, Study Says
February 21st 2019Researchers examined the medical costs for patients with a rare subset of chronic obstructive pulmonary disease (COPD) caused by a deficiency in alpha-1 antitrypsin receiving augmentation therapy.
Read More
Adding COPD Screenings to Drug Clinic Appointments Yields Benefits for Patients
February 15th 2019A UK study found that adding respiratory health screenings to drug clinic appointments for those trying to recover from heroin use was effective at uncovering chronic obstructive pulmonary disease (COPD) in this group of patients.
Read More
Investigating Manual Therapy as a Treatment for COPD
February 14th 2019There is not enough evidence that manual therapy—a clinical approach of using skilled, physical, hands-on procedures to improve function, lessen pain, and facilitate movement—can successfully be used to treat chronic obstructive pulmonary disease (COPD).
Read More
Community-Acquired Pneumonia Presents Burden for Patients With COPD
February 9th 2019A survey of patients with chronic obstructive pulmonary disease (COPD) who had contracted community-acquired pneumonia showed that the additional illness caused a significant burden, such as lost time from work, as well as a burden on their caregivers.
Read More
Long-Term Use of Statins Reduces Mortality, Inflammation in COPD, Review Says
January 31st 2019A recent review showed that the long-term use of statins reduced the risk of acute exacerbation in chronic obstructive pulmonary disease (COPD), heart disease–related mortality and all-cause mortality, as well as decreased inflammatory factors.
Read More
Study Tests Whether Asthma–COPD Overlap Is a Heterogeneous Condition
January 30th 2019Asthma–COPD overlap (ACO) is a term that encompasses patients with characteristics of 2 conditions, asthma and chronic obstructive pulmonary disease (COPD). A recent study from Spain sought to validate a proposed algorithm to help clinicians identify ACO among patients with COPD, in an effort to tailor treatment.
Read More
Phase 4 Study of Formoterol Fumarate Finds Safety Outcomes Similar to Placebo
January 26th 2019A phase 4 study of formoterol fumarate showed similar safety performance as placebo in patients with moderate-to-severe chronic obstructive pulmonary disease, according to a recently published study.
Read More
Adding Exercise to COPD Treatment Is Cost-Effective, Simulation Study Says
January 22nd 2019Researchers in the United Kingdom used a Markov microsimulation model comparing a population with chronic obstructive pulmonary disease (COPD) performing physical activity vs a COPD population that was sedentary, in order to estimate the cost-effectiveness of regular PA vs a sedentary lifestyle.
Read More
Researchers Document Links Between Pollution Levels, ED Visits for Breathing Problems
January 19th 2019Researchers investigating the associations between ground-level ozone and fine particulate pollution and emergency department (ED) visits for chronic obstructive pulmonary disease, asthma, and respiratory infections found that as levels rose, more patients land in the ED with breathing problems.
Read More
Researchers Say They've Found Tiny Extracellular Entity That Causes COPD Damage
January 15th 2019Researchers said they found a previously unreported pathogenic entity that links chronic inflammation and tissue destruction in the lungs of patients with chronic obstructive pulmonary disease (COPD).
Read More
Severe Dyspnea Influences COPD Treatment Response, Confirms Benefit of Combination Therapy
January 9th 2019When to begin maintenance therapy for patients with chronic obstructive pulmonary disease (COPD) with either a single drug, or a combination of long-acting bronchodilators, is not always clear. A new study looking at whether baseline symptomatic status influences response to treatment suggests that patients with more severe dyspnea benefit more from a combination of tiotropium/olodaterol than tiotropium alone.
Read More
ResMed Highlights Digital Health at JP Morgan Conference
January 8th 2019Chronic obstructive pulmonary disease is one of the world’s top drivers of chronic disease burdens, the chief executive officer of ResMed told the JP Morgan Healthcare Conference, as he explained the company’s strategy to help meet unmet needs using digital connectivity and data analytics.
Read More
COPD Exacerbations Tied to Increased Risks for Patients Who Also Have CAD
January 5th 2019A recent study looking at the impact of recent exacerbations of chronic obstructive pulmonary disease (COPD) on hospitalized patients who also have coronary artery disease (CAD) found that COPD was was independently associated with additional risks of complications after percutaneous coronary intervention.
Read More
Vaccination Cuts Risk of Severe Flu in Hospitalized Patients With COPD
January 5th 2019Hospitalized patients with chronic obstructive pulmonary disease (COPD) who tested positive for the flu and were unvaccinated had worse death rates and more severe illness than those who were vaccinated, according to a recent study.
Read More
No Difference Found in Smokers With COPD Trying Different Cessation Techniques
December 26th 2018Long-term nicotine replacement therapy (LT-NRT) provides 1 way for smokers with chronic obstructive pulmonary disease (COPD) to try to quit, but does not result in greater rates of cessation or harm reduction, according to a recently published study.
Read More
Examining ED Antibiotic Trends in Acute Exacerbations of COPD
December 25th 2018Current guidelines for chronic obstructive pulmonary disease (COPD) call for using antibiotics in the emergency department (ED) when presented with acute exacerbations of COPD (AECOPD). A recent study sought to determine the rate at which patients with AECOPD are treated with antibiotics and also looked at the proportions of antibiotic classes prescribed, trends of antibiotic treatment, and identified independent predictors of antibiotic therapy.
Read More
COPD Increases Risk of Death in Patients With Heart Failure
December 22nd 2018Increased severity of chronic obstructive pulmonary disease (COPD) was associated with an increased risk of mortality and hospitalization in patients with heart failure, according to a recent study published in JAMA Open.
Read More
Patients With Mild to Moderate COPD Differ Widely in Respiratory Symptoms
December 15th 2018Chronic obstructive pulmonary disease (COPD) is a heterogeneous disease, and patients can differ markedly in their rate of lung function decline and frequency of exacerbations. A recent study sought to determine what proportion of between-individual variability in symptoms can be explained by lung function versus all other observable characteristics.
Read More
Gender Differences Found in COPD Hospitalizations and In-Hospital Deaths
December 14th 2018A recent report, published by the Annals of the American Thoracic Society, assessed trends in chronic obstructive pulmonary disease (COPD) hospitalizations and in-hospital deaths in the United States and found that the number of in-hospital deaths for COPD has decreased; however, women account for a higher proportion of the hospitalizations and in-hospital deaths.
Read More
Study Identifies COPD Patient Subgroup Who Benefit Most From Roflumilast
December 8th 2018A recent study aimed to identify the characteristics of patients who demonstrate the greatest exacerbation risk reduction with roflumilast, finding that the medication is most successful in patients with prior hospitalization, greater exacerbation frequency, and higher baseline blood eosinophil count.
Read More
ResMed Buying COPD, Asthma Sensor Company Propeller Health
December 5th 2018Propeller Health, a digital health company that makes sensors to track patient use of respiratory inhalers used for chronic obstructive pulmonary disease (COPD) and asthma, is being snapped up by ResMed, which makes connected devices for respiratory care.
Read More
Is There An Impact on Lung Cancer Survival Due to COPD?
December 2nd 2018Researchers investigated the association between chronic obstructive pulmonary disease (COPD) phenotypes and the prognosis of different histological subtypes of lung cancer and found that COPD, especially emphysema-predominant phenotype, was an independent prognostic risk factor for squamous carcinoma only.
Read More
Effective Management of COPD in Primary Care: Challenges and Opportunities
November 30th 2018By meeting challenges in caring for patients with chronic obstructive pulmonary dieases head-on, primary care doctors have an opportunity to reduce the potential for unnecessary or sub-optimal care while improving patient outcomes.
Read More
A COPD Awareness Month Q&A With The COPD Foundation
November 29th 2018Chronic obstructive pulmonary disease (COPD) is the fourth leading cause of death in the United States, and for COPD Awareness Month this November, The American Journal of Managed Care® conducted a Q&A with Jamie Sullivan, MPH, vice president of public policy and outcomes for The COPD Foundation, as well as Chief Medical Officer Byron M. Thomashow, MD. The COPD Foundation is a not-for-profit organization that works to improve the lives of patients with COPD.
Read More